In vitro anti-inflammatory effect of picrasmalignan A by the inhibition of iNOS and COX‑2 expression in LPS‑activated macrophage RAW 264.7 cells

Zhao,Feng; Chen,Lei; Bi,Chenchen; Zhang,Menglin; Jiao,Weihua; Yao,Xinsheng

doi:10.3892/mmr.2013.1663

November 2013 Volume 8 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

November 2013 Volume 8 Issue 5

Full Size Image

Article

In vitro anti-inflammatory effect of picrasmalignan A by the inhibition of iNOS and COX‑2 expression in LPS‑activated macrophage RAW 264.7 cells

Authors:
- Feng Zhao
- Lei Chen
- Chenchen Bi
- Menglin Zhang
- Weihua Jiao
- Xinsheng Yao
View Affiliations / Copyright

Affiliations: School of Pharmacy, Yantai University, Laishan, Yantai, Shandong 264005, P.R. China, Department of Pharmacy, Changzheng Hospital, Second Military Medicinal University, Shanghai 200003, P.R. China, Institute of Traditional Chinese Medicine and Natural Products, Jinan University, Guangzhou, Guangdong 510632, P.R. China
Pages: 1575-1579
|
Published online on: August 30, 2013

https://doi.org/10.3892/mmr.2013.1663
Expand metrics +

Abstract

Picrasma quassioides (P. quassioides) has been widely used as a traditional Chinese medicine for clearing fever and detoxification. Previous phytochemical studies have identified a novel dihydrobenzofuran‑type neolignan, picrasmalignan A, isolated from the stems of P. quassioides. In the present study, the in vitro anti‑inflammatory effects and molecular mechanisms of picrasmalignan A have been investigated in cultured RAW 264.7 cells, a mouse macrophage‑like cell line. A Griess assay was used to demonstrate the inhibitory effect of picrasmalignan A on the overproduction of nitric oxide (NO). An enzyme‑linked immunosorbent assay was used to determine the levels of pro‑inflammatory cytokines, including tumor necrosis factor‑α (TNF‑α) and interleukin‑6 (IL‑6). The inhibitory effect on the enzymatic activity of cyclooxygenase 2 (COX‑2) and inducible nitric oxide synthase (iNOS) was observed by colorimetric and fluorimetric assays, respectively. Western blotting was conducted to detect the expression of iNOS and COX‑2. Results showed that picrasmalignan A suppressed lipopolysaccharide‑stimulated NO production and pro‑inflammatory cytokine secretion, including TNF‑α and IL‑6, in a dose‑dependent manner. It also significantly inhibited the expression and enzymatic activity of iNOS and COX‑2. These results may demonstrate the anti‑inflammatory mechanism of picrasmalignan A.

View Figures

View References

1	Ohmoto T and Koike K: Studies on the constituents of Picrasma quassioides Bennet I. On the alkaloidal constituents. Chem Pharm Bull. 30:1204–1209. 1982.
2	Ohmoto T and Koike K: Studies on the constituents of Picrasma quassioides Bennet II. On the alkaloidal constituents. Chem Pharm Bull. 31:3198–3204. 1983.
3	Ohmoto T and Koike K: Studies on the constituents of Picrasma quassioides Bennet III. The alkaloidal constituents. Chem Pharm Bull. 32:3579–3583. 1984.
4	Jiao WH, Gao H, Zhao F, He F, Zhou GX and Yao XS: A new neolignan and a new sesterterpenoid from the stems of Picrasma quassioides Bennet. Chem Biodivers. 8:1163–1169. 2011. View Article : Google Scholar : PubMed/NCBI
5	Jiao WH, Gao H, Zhao F, Lin HW, Pan YM, Zhou GX and Yao XS: Anti-inflammatory alkaloids from the stems of Picrasma quassioides Bennet. Chem Pharm Bull (Tokyo). 59:359–364. 2011. View Article : Google Scholar : PubMed/NCBI
6	Jiao WH, Gao H, Li CY, Zhao F, Jiang RW, Wang Y, Zhou GX and Yao XS: Quassidines A–D, bis-beta-carboline alkaloids from the stems of Picrasma quassioides. J Nat Prod. 73:167–171. 2010.
7	Jiao WH, Gao H, Li CY, Zhou GX, Kitanaka S, Ohmura A and Yao XS: Beta-carboline alkaloids from the stems of Picrasma quassioides. Magn Reson Chem. 48:490–495. 2010.PubMed/NCBI
8	Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G and Huber C: Serum levels of cytokines in chronic liver diseases. Gastroenterology. 103:264–274. 1992.PubMed/NCBI
9	Libby P, Ridker PM and Maseri A: Inflammation and atherosclerosis. Circulation. 105:1135–1143. 2002. View Article : Google Scholar : PubMed/NCBI
10	Isomäki P and Punnonen J: Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med. 29:499–507. 1997.
11	Pokharel YR, Liu QH, Oh JW, Woo ER and Kang KW: 4-Hydroxykobusin inhibits the induction of nitric oxide synthase by inhibiting NF-kappaB and AP-1 activation. Biol Pharm Bull. 30:1097–1101. 2007. View Article : Google Scholar : PubMed/NCBI
12	Emery P: COX-1, COX-2: so what? Scand J Rheumatol. 28:6–9. 1999. View Article : Google Scholar : PubMed/NCBI
13	Abd-El-Aleem SA, Ferguson MW, Appleton I, Bhowmick A, McCollum CN and Ireland GW: Expression of cyclooxygenase isoforms in normal human skin and chronic venous ulcers. J Pathol. 195:616–623. 2001. View Article : Google Scholar : PubMed/NCBI
14	Bruch-Gerharz D, Stahl W, Gerharz CD, Megahed M, Wingerath T, Sies H and Ruzicka T: Accumulation of the xanthophyll lutein in skin amyloid deposits of systemic amyloidosis (al type). J Invest Dermatol. 116:196–197. 2001. View Article : Google Scholar : PubMed/NCBI
15	Bruch-Gerharz D, Fehsel K, Suschek C, Michel G, Ruzicka T and Kolba-Bachofen V: A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med. 184:2007–2012. 1996. View Article : Google Scholar : PubMed/NCBI
16	Zhao F, Gao Z, Jiao W, Chen L, Chen L and Yao X: In vitro anti-inflammatory effects of beta-carboline alkaloids, isolated from Picrasma quassioides, through inhibition of the iNOS pathway. Planta Med. 78:1906–1911. 2012. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

In vitro anti-inflammatory effect of picrasmalignan A by the inhibition of iNOS and COX‑2 expression in LPS‑activated macrophage RAW 264.7 cells

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Related Articles